000 01063 a2200289 4500
005 20250512050531.0
264 0 _c19880603
008 198806s 0 0 eng d
022 _a0008-5472
040 _aNLM
_beng
_cNLM
100 1 _aHerman, T S
245 0 0 _aSequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
_h[electronic resource]
260 _bCancer research
_cMay 1988
300 _a2693-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aCisplatin
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aFibrosarcoma
_xpathology
650 0 4 _aHyperthermia, Induced
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C3H
700 1 _aTeicher, B A
773 0 _tCancer research
_gvol. 48
_gno. 10
_gp. 2693-7
999 _c3365180
_d3365180